Evidence map›Paper›PMID 23480192›Full record

ArticleClinical and experimental immunology2013

Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells.

J Lappalainen, J Rintahaka, P T Kovanen, S Matikainen, K K Eklund

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Novel Strategies to Target Mast Cells in Disease.Journal of innate immunity · 2021
    Review
  5. Article
  6. Article
  7. An overview of mast cell pattern recognition receptors.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2017
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

J LappalainenWihuri Research Institute, Helsinki, Finland. jani.lappalainen@helsinki.fi
J Rintahaka
P T Kovanen
S Matikainen
K K Eklund
Wihuri Research Institute · FIFinnish Institute of Occupational Health · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells have been implicated in the first line of defence against parasites and bacteria, but less is known about their role in anti-viral responses. Allergic diseases often exacerbate during viral infection, suggesting an increased activation of mast cells in the process. In this study we investigated human mast cell response to double-stranded RNA and viral infection. Cultured human mast cells were incubated with poly(I:C), a synthetic RNA analogue and live Sendai virus as a model of RNA parainfluenza virus infection, and analysed for their anti-viral response. Mast cells responded to intracellular poly(I:C) by inducing type 1 and type 3 interferons and TNF-α. In contrast, extracellular Toll-like receptor 3 (TLR)-3-activating poly(I:C) failed to induce such response. Infection of mast cells with live Sendai virus induced an anti-viral response similar to that of intracellular poly(I:C). Type 1, but not type 3 interferons, up-regulated the expression of melanoma differentiation-associated gene 5 (MDA-5) and retinoic acid-inducible gene-1 (RIG-1), and TLR-3, demonstrating that human mast cells do not express functional receptors for type 3 interferons. Furthermore, virus infection induced the anti-viral proteins MxA and IFIT3 in human mast cells. In conclusion, our results support the notion that mast cells can recognize an invading virus through intracellular virus sensors and produce high amounts of type 1 and type 3 interferons and the anti-viral proteins human myxovirus resistance gene A (MxA) and interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in response to the virus infection.

Indexed as

Cells, CulturedDEAD-box RNA HelicasesGene Expression RegulationGTP-Binding ProteinsHumansInterferon-Induced Helicase, IFIH1Interferon InducersInterferonsIntracellular Signaling Peptides and ProteinsMast CellsMyxovirus Resistance ProteinsPoly I-CReceptors, Retinoic AcidRNA, Double-StrandedSendai virusSignal TransductionDEAD-box RNA HelicasesGTP-Binding ProteinsIFIH1 protein, humanIFIT3 protein, humanInterferon-Induced Helicase, IFIH1Interferon InducersInterferonsIntracellular Signaling Peptides and ProteinsMX1 protein, humanMyxovirus Resistance ProteinsPLAAT4 protein, humanPoly I-CReceptors, Retinoic AcidRNA, Double-StrandedTLR3 protein, humanToll-Like Receptor 3Tumor Necrosis Factor-alpha

Identifiers

PMID23480192
PMCPMC3719938
OpenAlexW1822871440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.